Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Boehringer Ingelheim
Julphar
Chubb
Queensland Health
Citi
Argus Health
McKinsey
Mallinckrodt

Generated: April 20, 2018

DrugPatentWatch Database Preview

MYCOSTATIN Drug Profile

« Back to Dashboard

When do Mycostatin patents expire, and what generic alternatives are available?

Mycostatin is a drug marketed by Delcor Asset Corp and is included in seven NDAs.

The generic ingredient in MYCOSTATIN is nystatin. There are eight drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the nystatin profile page.
Summary for MYCOSTATIN
Drug patent expirations by year for MYCOSTATIN
Medical Subject Heading (MeSH) Categories for MYCOSTATIN

US Patents and Regulatory Information for MYCOSTATIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Delcor Asset Corp MYCOSTATIN nystatin CREAM;TOPICAL 060575-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Delcor Asset Corp MYCOSTATIN nystatin TABLET;VAGINAL 060577-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Delcor Asset Corp MYCOSTATIN nystatin POWDER;TOPICAL 060578-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Delcor Asset Corp MYCOSTATIN nystatin OINTMENT;TOPICAL 060571-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Chubb
Chinese Patent Office
Medtronic
Queensland Health
Covington
Cerilliant
UBS
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.